1. Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy
   Changjing Huang et al, 2024, BMC Cancer CrossRef
2. Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2
   Takuya Shimada et al, 2015, Journal of Pharmaceutical Sciences CrossRef
3. Pancreatic Cancer: A Review of Current Treatment and Novel Therapies
   Hordur Mar Kolbeinsson et al, 2023, Journal of Investigative Surgery CrossRef
4. Solid pseudopapillary neoplasm of the pancreas: Clinical-pathological features and management, a single-center experience
   Carsten Palnaes Hansen et al, 2019, Rare Tumors CrossRef
5. Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer
   Shinya Endo et al, 2021, Internal Medicine CrossRef
6. Combined Therapy of Chemotherapy and Radiofrequency Ablation for Pancreatic Cancer Patients With Metachronous Hepatic Metastatic Lesions After Radical Pancreatic Resection
   L. T. Wang et al, 2024, Cancer Control CrossRef
7. Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells
   Masato Hioki et al, 2018, Biopharmaceutics & Drug Disposition CrossRef
8. Antineoplastics
   , 2014, Reactions Weekly CrossRef
9. Neoadjuvant chemotherapy with gemcitabine‑based regimens improves the prognosis of node positive resectable pancreatic head cancer
   Hidehiro Tajima et al, 2019, Molecular and Clinical Oncology CrossRef
10. Curative Resection for Metastatic Solid Pseudopapillary Neoplasm of Pancreas—a Case Series
    Aparna M. Jagannathan et al, 2024, Indian Journal of Surgical Oncology CrossRef